Keyphrases
Asthma
77%
Early Risk
55%
Early childhood
55%
Allergic Rhinitis
55%
Bacterial Microbiome
55%
Traditional Chinese Medicinal
55%
Compassionate Use
55%
Atopic Disease
55%
Bacille Calmette-Guérin
55%
Bradyarrhythmia
55%
Confidence Interval
55%
Vaccination
55%
Systematic Meta-analysis
55%
Nasal
55%
Treatment Outcome
55%
Healthy Controls
55%
Meta-analysis
55%
Odds Ratio
55%
Bacillus Calmette-Guérin Vaccine
33%
Use Studies
27%
Rhinitis
22%
Developed Countries
22%
Eczema
22%
Nasal Microbiota
20%
Atrioventricular Block
13%
Syncope
13%
Multifactor Regression Analysis
13%
Treatment-related Adverse Events
13%
Primary Outcome Measure
13%
Xerostomia
13%
Unfavorable Outcome
13%
Sleepiness
13%
Constipation
13%
Current Smoking
13%
Chinese Herbal Medicine
13%
Serious Adverse Events
13%
Low Socioeconomic Status
13%
Twice Daily
13%
Randomized Clinical Trial
13%
Intention-to-treat
13%
Beijing China
13%
Dropout
13%
Potential Correlation
11%
Vaccinated children
11%
Intervention Outcome
11%
Asthma Development
11%
Early Administration
11%
Intervention Studies
11%
Asthma Prevalence
11%
Random Effects
11%
Pharmacology, Toxicology and Pharmaceutical Science
Mycobacterium Bovis BCG
55%
Atopy
55%
Bradycardia
55%
Vaccination Policy
55%
Asthma
44%
Adverse Event
37%
BCG Vaccine
33%
Rhinitis
22%
Eczema
22%
Faintness
18%
Atrioventricular Block
18%
Xerostomia
18%
Constipation
18%
Randomized Clinical Trial
18%
Somnolence
18%
Prevalence
11%
Immunology and Microbiology
Asthma
100%
Bacterial Microbiome
55%
Mycobacterium Bovis BCG
55%
Allergic Rhinitis
55%
Vaccination Policy
55%
Atopy
55%
BCG Vaccine
33%
Rhinitis
22%
Eczema
22%
Nasal Microbiome
12%
Cochrane Library
11%
Medline
11%
Prevalence
11%